Logo image of CRK

COMSTOCK RESOURCES INC (CRK) Stock Fundamental Analysis

NYSE:CRK - New York Stock Exchange, Inc. - US2057683029 - Common Stock - Currency: USD

18.16  -0.45 (-2.42%)

After market: 18.16 0 (0%)

Fundamental Rating

2

CRK gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 212 industry peers in the Oil, Gas & Consumable Fuels industry. Both the profitability and financial health of CRK have multiple concerns. CRK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CRK has reported negative net income.
In the past year CRK had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CRK reported negative net income in multiple years.
Each year in the past 5 years CRK had a positive operating cash flow.
CRK Yearly Net Income VS EBIT VS OCF VS FCFCRK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B -1B 2B

1.2 Ratios

With a Return On Assets value of -1.01%, CRK is not doing good in the industry: 77.18% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -2.77%, CRK is doing worse than 74.76% of the companies in the same industry.
Industry RankSector Rank
ROA -1.01%
ROE -2.77%
ROIC N/A
ROA(3y)5.84%
ROA(5y)3.46%
ROE(3y)12.11%
ROE(5y)7.08%
ROIC(3y)N/A
ROIC(5y)N/A
CRK Yearly ROA, ROE, ROICCRK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400 600

1.3 Margins

CRK's Operating Margin has declined in the last couple of years.
CRK has a Gross Margin (53.90%) which is in line with its industry peers.
In the last couple of years the Gross Margin of CRK has declined.
The Profit Margin and Operating Margin are not available for CRK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.9%
OM growth 3Y-8.67%
OM growth 5Y-19.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.8%
GM growth 5Y-6.83%
CRK Yearly Profit, Operating, Gross MarginsCRK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

0

2. Health

2.1 Basic Checks

CRK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CRK has more shares outstanding
Compared to 5 years ago, CRK has more shares outstanding
CRK has a worse debt/assets ratio than last year.
CRK Yearly Shares OutstandingCRK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M
CRK Yearly Total Debt VS Total AssetsCRK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.07, we must say that CRK is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.07, CRK perfoms like the industry average, outperforming 41.75% of the companies in the same industry.
A Debt/Equity ratio of 1.28 is on the high side and indicates that CRK has dependencies on debt financing.
CRK's Debt to Equity ratio of 1.28 is on the low side compared to the rest of the industry. CRK is outperformed by 77.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Altman-Z 1.07
ROIC/WACCN/A
WACC8.59%
CRK Yearly LT Debt VS Equity VS FCFCRK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B

2.3 Liquidity

CRK has a Current Ratio of 0.60. This is a bad value and indicates that CRK is not financially healthy enough and could expect problems in meeting its short term obligations.
CRK's Current ratio of 0.60 is on the low side compared to the rest of the industry. CRK is outperformed by 83.50% of its industry peers.
A Quick Ratio of 0.60 indicates that CRK may have some problems paying its short term obligations.
CRK's Quick ratio of 0.60 is on the low side compared to the rest of the industry. CRK is outperformed by 79.13% of its industry peers.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.6
CRK Yearly Current Assets VS Current LiabilitesCRK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for CRK have decreased strongly by -121.13% in the last year.
CRK shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 18.84% yearly.
CRK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -49.44%.
Measured over the past years, CRK shows a very strong growth in Revenue. The Revenue has been growing by 32.02% on average per year.
EPS 1Y (TTM)-121.13%
EPS 3Y18.84%
EPS 5YN/A
EPS Q2Q%-525%
Revenue 1Y (TTM)-49.44%
Revenue growth 3Y22.18%
Revenue growth 5Y32.02%
Sales Q2Q%-19.18%

3.2 Future

CRK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 71.48% yearly.
CRK is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.03% yearly.
EPS Next Y-181.12%
EPS Next 2Y12.96%
EPS Next 3Y33.11%
EPS Next 5Y71.48%
Revenue Next Year-16.15%
Revenue Next 2Y6.38%
Revenue Next 3Y10.03%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CRK Yearly Revenue VS EstimatesCRK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
CRK Yearly EPS VS EstimatesCRK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRK. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 30.28, which means the current valuation is very expensive for CRK.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CRK indicates a slightly more expensive valuation: CRK is more expensive than 68.93% of the companies listed in the same industry.
CRK is valuated cheaply when we compare the Price/Forward Earnings ratio to 92.74, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 30.28
CRK Price Earnings VS Forward Price EarningsCRK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

65.53% of the companies in the same industry are cheaper than CRK, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.45
CRK Per share dataCRK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

CRK's earnings are expected to grow with 33.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y12.96%
EPS Next 3Y33.11%

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.74%, CRK is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 6.57, CRK pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.28, CRK pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.74%

5.2 History

CRK has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
CRK Yearly Dividends per shareCRK Yearly Dividends per shareYearly Dividends per share 2022 2023 0.1 0.2 0.3 0.4 0.5

5.3 Sustainability

CRK has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-54.83%
EPS Next 2Y12.96%
EPS Next 3Y33.11%
CRK Yearly Income VS Free CF VS DividendCRK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M -500M 1B -1B

More info and screens

COMSTOCK RESOURCES INC

NYSE:CRK (2/4/2025, 8:04:00 PM)

After market: 18.16 0 (0%)

18.16

-0.45 (-2.42%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)10-30 2024-10-30/amc
Earnings (Next)02-18 2025-02-18/amc
Inst Owners35.07%
Inst Owner Change-1.87%
Ins Owners2.04%
Ins Owner Change6.12%
Market Cap5.31B
Analysts52.38
Price Target15.63 (-13.93%)
Short Float %32.26%
Short Ratio10.12
Dividend
Industry RankSector Rank
Dividend Yield 4.74%
Yearly Dividend0.5
Dividend Growth(5Y)N/A
DP-54.83%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-13.59%
Min EPS beat(2)-22.17%
Max EPS beat(2)-5.01%
EPS beat(4)1
Avg EPS beat(4)2.41%
Min EPS beat(4)-22.17%
Max EPS beat(4)58.16%
EPS beat(8)2
Avg EPS beat(8)-11%
EPS beat(12)4
Avg EPS beat(12)-8.68%
EPS beat(16)7
Avg EPS beat(16)3.3%
Revenue beat(2)0
Avg Revenue beat(2)-12.22%
Min Revenue beat(2)-17.72%
Max Revenue beat(2)-6.71%
Revenue beat(4)1
Avg Revenue beat(4)-6.42%
Min Revenue beat(4)-17.72%
Max Revenue beat(4)2.28%
Revenue beat(8)4
Avg Revenue beat(8)2.07%
Revenue beat(12)8
Avg Revenue beat(12)24.49%
Revenue beat(16)12
Avg Revenue beat(16)21.29%
PT rev (1m)32.75%
PT rev (3m)58.25%
EPS NQ rev (1m)-19.33%
EPS NQ rev (3m)-83.99%
EPS NY rev (1m)-0.51%
EPS NY rev (3m)-8.42%
Revenue NQ rev (1m)-2.35%
Revenue NQ rev (3m)-13.69%
Revenue NY rev (1m)-0.77%
Revenue NY rev (3m)-2.27%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 30.28
P/S 4.09
P/FCF N/A
P/OCF 9.13
P/B 2.31
P/tB 2.71
EV/EBITDA 12.45
EPS(TTM)-0.3
EYN/A
EPS(NY)0.6
Fwd EY3.3%
FCF(TTM)-1.96
FCFYN/A
OCF(TTM)1.99
OCFY10.96%
SpS4.44
BVpS7.85
TBVpS6.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.01%
ROE -2.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.9%
FCFM N/A
ROA(3y)5.84%
ROA(5y)3.46%
ROE(3y)12.11%
ROE(5y)7.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)25.53%
ROCE(5y)17.39%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-8.67%
OM growth 5Y-19.01%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.8%
GM growth 5Y-6.83%
F-Score3
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 1.28
Debt/FCF N/A
Debt/EBITDA 4.45
Cap/Depr 148.13%
Cap/Sales 88.9%
Interest Coverage N/A
Cash Conversion 87.83%
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.6
Altman-Z 1.07
F-Score3
WACC8.59%
ROIC/WACCN/A
Cap/Depr(3y)199.81%
Cap/Depr(5y)179.54%
Cap/Sales(3y)52.58%
Cap/Sales(5y)56.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-121.13%
EPS 3Y18.84%
EPS 5YN/A
EPS Q2Q%-525%
EPS Next Y-181.12%
EPS Next 2Y12.96%
EPS Next 3Y33.11%
EPS Next 5Y71.48%
Revenue 1Y (TTM)-49.44%
Revenue growth 3Y22.18%
Revenue growth 5Y32.02%
Sales Q2Q%-19.18%
Revenue Next Year-16.15%
Revenue Next 2Y6.38%
Revenue Next 3Y10.03%
Revenue Next 5YN/A
EBIT growth 1Y-113.89%
EBIT growth 3Y11.59%
EBIT growth 5Y6.92%
EBIT Next Year182.39%
EBIT Next 3Y68.52%
EBIT Next 5Y46.09%
FCF growth 1Y-215.49%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-59.76%
OCF growth 3Y20.88%
OCF growth 5Y40.16%